Oral Solid Dosage Pharmaceutical Formulation Market is projected to achieve US$ 8,95,636.0 million by 2034 at a CAGR of 3.7%.

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Novo Nordisk’s NVO oral obesity pill, amycretin, showed faster weight loss than its blockbuster weekly injection, Wegovy (semaglutide), in a phase I study. Not only did NVO’s stock rise 4% in response ...

Steroids are a huge part of bodybuilding and performance enhancement. However, it is very important to know the oral steroids ...

Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

U.S. Food and Drug Administration approves Zenrelia, a once-daily oral JAK inhibitor for dogs with allergic and ... compared ...

Oral Controlled Release Drug Delivery Technology Market is anticipated to reach a valuation of about USD 68.4 billion by 2032 ...

Shares of Novo Nordisk NVO gained 4.2% on Sept. 11 after the company presented encouraging detailed efficacy data from the early-stage study of its new, investigational oral obesity pill, amycretin, ...

The first-in-human study has found that participants who received 50mg amycretin reduced their body weight by 10.4 per cent ...

Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an ...

Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an ...

Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an ...